ABVC logo

ABVC BioPharma (ABVC) Current Assets

Annual Current Assets

$1.66 M
-$1.33 M-44.54%

December 31, 2023


Summary


Performance

ABVC Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABVCbalance sheetmetrics:

Quarterly Current Assets

$2.15 M
-$41.30 K-1.89%

September 30, 2024


Summary


Performance

ABVC Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABVCbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

ABVC Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-44.5%-13.8%
3 y3 years-73.2%-69.8%
5 y5 years+1620.3%-69.8%

ABVC Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-78.3%at low-78.0%+29.7%
5 y5-year-78.3%+88.7%-78.0%+167.7%
alltimeall time-78.3%>+9999.0%-78.0%-100.0%

ABVC BioPharma Current Assets History

DateAnnualQuarterly
Sep 2024
-
$2.15 M(-1.9%)
Jun 2024
-
$2.19 M(+22.0%)
Mar 2024
-
$1.79 M(+8.3%)
Dec 2023
$12.84 M(+94.7%)
$1.66 M(-33.6%)
Sep 2023
-
$2.49 M(+17.1%)
Jun 2023
-
$2.13 M(-38.8%)
Mar 2023
-
$3.48 M(+16.5%)
Dec 2022
$6.59 M(+9.1%)
$2.99 M(+2.9%)
Sep 2022
-
$2.90 M(-70.3%)
Jun 2022
-
$9.79 M(+22.6%)
Mar 2022
-
$7.99 M(+4.4%)
Dec 2021
$6.04 M(+11.2%)
$7.65 M(+7.6%)
Sep 2021
-
$7.11 M(+96.0%)
Jun 2021
-
$3.63 M(-30.3%)
Mar 2021
-
$5.21 M(-15.7%)
Dec 2020
$5.43 M(-10.2%)
$6.17 M(+424.1%)
Sep 2020
-
$1.18 M(-26.6%)
Jun 2020
-
$1.60 M(+100.0%)
Mar 2020
-
$802.50 K(-8.6%)
Dec 2019
$6.05 M(>+9900.0%)
$878.20 K(-48.6%)
Sep 2019
-
$1.71 M(+38.4%)
Jun 2019
-
$1.23 M(-19.2%)
Mar 2019
-
$1.53 M(+1485.9%)
Dec 2018
$0.00(0.0%)
$96.30 K(-96.3%)
Sep 2018
-
$2.59 M(-2.1%)
Jun 2018
-
$2.65 M(+3.7%)
Mar 2018
-
$2.56 M(-3.3%)
Dec 2017
$0.00(0.0%)
$2.64 M(-4.1%)
Sep 2017
-
$2.75 M(>+9900.0%)
Sep 2017
$0.00(-100.0%)
-
Jun 2017
-
$8100.00(-92.4%)
Mar 2017
-
$106.40 K(+472.0%)
Dec 2016
-
$18.60 K(-89.3%)
Sep 2016
$3800.00(0.0%)
$173.50 K(-95.2%)
Jun 2016
-
$3.58 M(+310.8%)
Mar 2016
-
$872.60 K(>+9900.0%)
Dec 2015
-
$300.00(-100.0%)
Sep 2015
$3800.00(-94.1%)
$998.60 K(>+9900.0%)
Jun 2015
-
$2800.00(>+9900.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
-
$0.00(-100.0%)
Sep 2014
$64.60 K
$800.00(-55.6%)
DateAnnualQuarterly
Jun 2014
-
$1800.00(0.0%)
Mar 2014
-
$1800.00(0.0%)
Dec 2013
-
$1800.00(-5.3%)
Sep 2013
$230.10 K(-9.4%)
$1900.00(0.0%)
Jun 2013
-
$1900.00(-85.7%)
Mar 2013
-
$13.30 K(-48.4%)
Dec 2012
-
$25.80 K(-46.6%)
Sep 2012
$254.00 K(-5.0%)
$48.30 K(-58.3%)
Jun 2012
-
$115.70 K(+430.7%)
Mar 2012
-
$21.80 K(-58.6%)
Dec 2011
-
$52.70 K(-48.3%)
Sep 2011
$267.50 K(+2.6%)
$101.90 K(-14.9%)
Jun 2011
-
$119.70 K(+172.0%)
Mar 2011
-
$44.00 K(-6.0%)
Dec 2010
-
$46.80 K(+41.0%)
Sep 2010
$260.80 K(-49.5%)
$33.20 K(-43.4%)
Jun 2010
-
$58.70 K(+4092.9%)
Mar 2010
-
$1400.00(-95.9%)
Dec 2009
-
$34.20 K(+2342.9%)
Sep 2009
$516.80 K(+2.9%)
$1400.00(-75.4%)
Jun 2009
-
$5700.00(+3.6%)
Mar 2009
-
$5500.00(-38.2%)
Dec 2008
-
$8900.00(-99.1%)
Sep 2008
$502.40 K(+55.1%)
$999.50 K(+1672.2%)
Jun 2008
-
$56.40 K(-72.7%)
Mar 2008
-
$206.50 K(+66.8%)
Dec 2007
-
$123.80 K(+8.6%)
Sep 2007
$324.00 K(>+9900.0%)
-
Jun 2007
-
$114.00 K(-13.0%)
Mar 2007
-
$131.00 K(+48.4%)
Dec 2006
$0.00(0.0%)
$88.30 K(+74.2%)
Sep 2006
-
$50.70 K(-0.8%)
Jun 2006
-
$51.10 K(-14.7%)
Mar 2006
-
$59.90 K(-5.5%)
Dec 2005
$0.00(0.0%)
$63.40 K(-11.7%)
Sep 2005
-
$71.80 K(-9.7%)
Jun 2005
-
$79.50 K(-6.8%)
Mar 2005
-
$85.30 K(-5.5%)
Dec 2004
$0.00(0.0%)
$90.30 K(-9.2%)
Sep 2004
-
$99.40 K(+26.0%)
Jun 2004
-
$78.90 K(-4.5%)
Mar 2004
-
$82.60 K
Dec 2003
$0.00
-

FAQ

  • What is ABVC BioPharma annual total current assets?
  • What is the all time high annual current assets for ABVC BioPharma?
  • What is ABVC BioPharma annual current assets year-on-year change?
  • What is ABVC BioPharma quarterly total current assets?
  • What is the all time high quarterly current assets for ABVC BioPharma?
  • What is ABVC BioPharma quarterly current assets year-on-year change?

What is ABVC BioPharma annual total current assets?

The current annual current assets of ABVC is $1.66 M

What is the all time high annual current assets for ABVC BioPharma?

ABVC BioPharma all-time high annual total current assets is $7.65 M

What is ABVC BioPharma annual current assets year-on-year change?

Over the past year, ABVC annual total current assets has changed by -$1.33 M (-44.54%)

What is ABVC BioPharma quarterly total current assets?

The current quarterly current assets of ABVC is $2.15 M

What is the all time high quarterly current assets for ABVC BioPharma?

ABVC BioPharma all-time high quarterly total current assets is $9.79 M

What is ABVC BioPharma quarterly current assets year-on-year change?

Over the past year, ABVC quarterly total current assets has changed by -$345.20 K (-13.84%)